JOSD2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.33002506178082E-12 |
Normal-vs-Stage2 |
2.19309999999195E-05 |
Normal-vs-Stage3 |
5.48450174164827E-13 |
Normal-vs-Stage4 |
1.626032641866E-12 |
Stage1-vs-Stage2 |
4.860600E-01 |
Stage1-vs-Stage3 |
2.497400E-01 |
Stage1-vs-Stage4 |
2.523900E-03 |
Stage2-vs-Stage3 |
9.172400E-01 |
Stage2-vs-Stage4 |
1.797400E-01 |
Stage3-vs-Stage4 |
7.794000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62447832963153E-12 |
Normal-vs-AfricanAmerican |
1.16679998996005E-11 |
Normal-vs-Asian |
1.021050E-01 |
Caucasian-vs-AfricanAmerican |
4.91609999997422E-06 |
Caucasian-vs-Asian |
3.575400E-01 |
AfricanAmerican-vs-Asian |
8.985800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62436730732907E-12 |
Normal-vs-Female |
1.63147273468667E-12 |
Male-vs-Female |
6.767000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
5.90149999999401E-05 |
Normal-vs-Age(41-60Yrs) |
1.62436730732907E-12 |
Normal-vs-Age(61-80Yrs) |
1.66766600528945E-12 |
Normal-vs-Age(81-100Yrs) |
4.599000E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.726600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.383200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.960800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.710200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.573000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.208600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.675300E-03 |
Normal-vs-Grade 2 |
1.48850043402149E-10 |
Normal-vs-Grade 3 |
1.62447832963153E-12 |
Normal-vs-Grade 4 |
1.67743596790615E-12 |
Grade 1-vs-Grade 2 |
3.276000E-01 |
Grade 1-vs-Grade 3 |
5.945600E-01 |
Grade 1-vs-Grade 4 |
6.998000E-01 |
Grade 2-vs-Grade 3 |
9.034200E-02 |
Grade 2-vs-Grade 4 |
2.076000E-03 |
Grade 3-vs-Grade 4 |
5.415700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.24179999616558E-09 |
Normal-vs-ccB subtype |
3.57480045565239E-10 |
ccA subtype-vs-ccB subtype |
9.106300E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.18696197104873E-12 |
Normal-vs-N1 |
7.987800E-04 |
N0-vs-N1 |
1.431030E-01 |
|
|